pEBB Flag GCN5 Citations (6)
Originally described in: GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA.Mao X, Gluck N, Li D, Maine GN, Li H, Zaidi IW, Repaka A, Mayo MW, Burstein E Genes Dev. 2009 Apr 1;23(7):849-61. doi: 10.1101/gad.1748409. PubMed Journal
Articles Citing pEBB Flag GCN5
| Articles |
|---|
| Opposite effects of GCN5 and PCAF knockdowns on the alternative mechanism of telomere maintenance. Jeitany M, Bakhos-Douaihy D, Silvestre DC, Pineda JR, Ugolin N, Moussa A, Gauthier LR, Busso D, Junier MP, Chneiweiss H, Chevillard S, Desmaze C, Boussin FD. Oncotarget. 2017 Apr 18;8(16):26269-26280. doi: 10.18632/oncotarget.15447. PubMed |
| LC-MS/MS-based quantitative study of the acyl group- and site-selectivity of human sirtuins to acylated nucleosomes. Tanabe K, Liu J, Kato D, Kurumizaka H, Yamatsugu K, Kanai M, Kawashima SA. Sci Rep. 2018 Feb 8;8(1):2656. doi: 10.1038/s41598-018-21060-2. PubMed |
| Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis. Kumari R, Deshmukh RS, Das S. Nat Commun. 2019 Sep 18;10(1):4255. doi: 10.1038/s41467-019-12194-6. PubMed |
| Acetylation-dependent regulation of BRAF oncogenic function. Dai X, Zhang X, Yin Q, Hu J, Guo J, Gao Y, Snell AH, Inuzuka H, Wan L, Wei W. Cell Rep. 2022 Jan 18;38(3):110250. doi: 10.1016/j.celrep.2021.110250. PubMed |
| Histone malonylation is regulated by SIRT5 and KAT2A. Zhang R, Bons J, Scheidemantle G, Liu X, Bielska O, Carrico C, Rose J, Heckenbach I, Scheibye-Knudsen M, Schilling B, Verdin E. iScience. 2023 Feb 13;26(3):106193. doi: 10.1016/j.isci.2023.106193. eCollection 2023 Mar 17. PubMed |
| The incorporation of acetylated LAP-TGF-beta1 proteins into exosomes promotes TNBC cell dissemination in lung micro-metastasis. Yu P, Han Y, Meng L, Tang Z, Jin Z, Zhang Z, Zhou Y, Luo J, Luo J, Han C, Zhang C, Kong L. Mol Cancer. 2024 Apr 25;23(1):82. doi: 10.1186/s12943-024-01995-z. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.